ScopusElsevier Scopus
Status
Active
Coverage
2018–present
Source type
Journal
Open access
Yes
CiteScore
3.6
Best quartile
Q2 · 52nd pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Rheumatology | 37 / 77 | 52nd | Q2 |
Advances in Rheumatology
ISSN 2523-3106
Publisher: BioMed Central Ltd
Scopus · Q2WoS · SCIEOpen Access
Is Advances in Rheumatology indexed in Scopus? Yes — actively indexed in Scopus, coverage 2018–present, best quartile Q2, CiteScore 3.6.
What is the impact factor of Advances in Rheumatology? Advances in Rheumatology is indexed in the Science Citation Index Expanded, so Clarivate publishes a Journal Impact Factor for it in the Journal Citation Reports. JCR is a paid Clarivate product, so the JIF value is not free to republish. Its closest free equivalent is the Scopus CiteScore 3.6, which places it in quartile Q2 at the 52nd percentile of its subject.
Is Advances in Rheumatology in Web of Science? Yes — indexed in the Science Citation Index Expanded.
Is Advances in Rheumatology open access? Yes — it is an open-access journal, listed in DOAJ.
3.6
CiteScore 2025
Scopus
Q2
Best quartile
rank 37 of 77 · 52nd pctile
3
Indexed in
major indexes
Cost to publish: Checking DOAJ for article charges…
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Listed in DOAJ
Open accessFully open access, peer reviewed
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.
Official sources & links
Related journals
Explore this journal in the interactive dashboard →
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.